STIM Neuronetics Inc
Price (delayed)
$3.94
Market cap
$259.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.38
Enterprise value
$322.48M
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial
Highlights
The gross profit has grown by 4.8% YoY
The revenue has grown by 5% YoY and by 3% from the previous quarter
STIM's equity has surged by 195% since the previous quarter but it is down by 19% year-on-year
The company's debt has surged by 70% QoQ and by 32% YoY
Neuronetics's quick ratio has plunged by 64% YoY and by 41% from the previous quarter
Key stats
What are the main financial stats of STIM
Market
Valuations
Earnings
Shares outstanding
65.81M
Market cap
$259.31M
Enterprise value
$322.48M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.32
Price to sales (P/S)
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.31
Revenue
$74.89M
Gross profit
$54.16M
Operating income
-$34.56M
Net income
-$43.71M
EBIT
-$36.42M
EBITDA
-$34.35M
Free cash flow
-$32.46M
Per share
Balance sheet
Liquidity
EPS
-$1.38
EPS diluted
-$1.38
Free cash flow per share
-$1.02
Book value per share
$0.91
Revenue per share
$2.36
TBVPS
$3.24
Total assets
$140.9M
Total liabilities
$109.1M
Debt
$82.63M
Equity
$27.71M
Working capital
$26.86M
Debt to equity
2.98
Current ratio
1.86
Quick ratio
1.41
Net debt/EBITDA
-1.84
Margins
Efficiency
Dividend
EBITDA margin
-45.9%
Gross margin
72.3%
Net margin
-58.4%
Operating margin
-46.2%
Return on assets
-42.1%
Return on equity
-207.8%
Return on invested capital
-35.4%
Return on capital employed
-33.2%
Return on sales
-48.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STIM stock price
How has the Neuronetics stock price performed over time
Intraday
4.23%
1 week
-3.43%
1 month
-7.29%
1 year
-13.22%
YTD
144.72%
QTD
7.07%
Financial performance
How have Neuronetics's revenue and profit performed over time
Revenue
$74.89M
Gross profit
$54.16M
Operating income
-$34.56M
Net income
-$43.71M
Gross margin
72.3%
Net margin
-58.4%
The net income has contracted by 45% YoY and by 20% from the previous quarter
The company's net margin fell by 38% YoY and by 17% QoQ
STIM's operating income is down by 26% from the previous quarter and by 13% YoY
The company's operating margin fell by 22% QoQ and by 8% YoY
Growth
What is Neuronetics's growth rate over time
Valuation
What is Neuronetics stock price valuation
P/E
N/A
P/B
4.32
P/S
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.31
STIM's EPS is down by 31% YoY and by 13% from the previous quarter
STIM's equity has surged by 195% since the previous quarter but it is down by 19% year-on-year
STIM's price to book (P/B) is 59% more than its 5-year quarterly average of 2.6 and 38% more than its last 4 quarters average of 3.0
The P/S is 78% above the last 4 quarters average of 0.9 but 24% below the 5-year quarterly average of 2.1
The revenue has grown by 5% YoY and by 3% from the previous quarter
Efficiency
How efficient is Neuronetics business performance
The ROE has plunged by 185% YoY and by 29% from the previous quarter
The return on assets has declined by 44% year-on-year and by 13% since the previous quarter
STIM's ROS is down by 40% YoY and by 22% from the previous quarter
STIM's ROIC is down by 19% YoY and by 15% from the previous quarter
Dividends
What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STIM.
Financial health
How did Neuronetics financials performed over time
The total assets is 29% more than the total liabilities
The total assets has soared by 90% from the previous quarter and by 22% YoY
The company's total liabilities has surged by 69% QoQ and by 34% YoY
The company's debt is 198% higher than its equity
STIM's equity has surged by 195% since the previous quarter but it is down by 19% year-on-year
The company's debt has surged by 70% QoQ and by 32% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.